Combination studies of platinum(ii)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin

Comparative analyses of cytotoxicity and molecular mechanisms between platinum metallointercalators and cisplatin

(2012) Shaoyu Wang et al.   Metallomics

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Pt(ii) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies

(2011) Carla Francisco et al.   DALTON TRANSACTIONS

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy

(2010) S. Ganapathy-Kanniappan et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

(2009) Francesca Greco et al.   ADVANCED DRUG DELIVERY REVIEWS

Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent

(2009) P. Dell'Antone   Medicinal Chemistry

In vivo studies of a platinum(ii) metallointercalator

(2008) Dianne M. Fisher et al.   CHEMICAL COMMUNICATIONS

Degradation of Bidentate-Coordinated Platinum(II)-Based DNA Intercalators by Reducedl-Glutathione

(2008) Sharon Kemp et al.   JOURNAL OF MEDICINAL CHEMISTRY